Tag Archives: Harris & Harris

Nanotechnology is an enabling technology not an industry sector

Over the years I’ve heard people point out that nanotechnology isn’t really a technology in the traditional sense. It is instead a means of describing applied science performed at the molecular level.  In short, chemistry, physics, engineering, and biology at the molecular level.

An Oct. 9, 2015 article by Kevin Kelleher for Time magazine points that fact out in detail focusing largely on the business end of things (Note: Links have been removed),

Of all the investment fads and manias over the past few decades, none have been as big of a fizzle as the craze for nanotech stocks. Ten years ago, venture capitalists were scrambling for investments, startups with “nano” in their names flourished and even a few nanotech funds launched hoping to track a rising industry.

Back in 2005, the year when nanotech mania peaked, a gold rush mentality took hold. There were 1,200 nanotech startups worldwide, half of them in the U.S. VCs invested more than $1 billion in nanotech in the first half of the decade. Draper Fisher Jurvetson had nearly a fifth of its portfolio in the nanotech sector, and Steve Jurvetson proclaimed it “the next great technology wave.”

Ten years on, precious few of the nanotech stocks and venture-backed startups have delivered on their investment promise. Harris & Harris and Arrowhead are both trading at less than a tenth of their respective peaks of the last decade. Invesco liquidated its PowerShares Lux Nanotech ETF in 2014, after it underperformed the S&P 500 for seven of the previous eight years.

And many of the surviving companies that touted their nanotech credentials or put “nano” in their names now describe themselves as materials companies, or semiconductor companies, or – like Arrowhead – biopharma companies, if they haven’t changed their names entirely.

The rebranding process has been an interesting one to observe. I had Neil Branda  (professor at Simon Fraser University [Vancouver, Canada] and executive director of their 4D Labs) explain to me last year (2014) that nanotechnology was a passé term, it is now all about advanced materials.

They’re right and they’re wrong. I think rebranding companies is possible and a good idea. Locally, Pangaea Ventures is now an Advanced Materials venture capitalism company. Coincidentally, Neil Branda’s startup (scroll down about 15% of the way), Switch Materials, is in their portfolio.

However, the term nanotechnology is some 40 years old and represents an enormous social capital investment. While it’s possible it will disappear that won’t be happening for a long, long time.

Nano and the NASDAQ

First, a caveat: I know very little about stock markets and investing so I’m not offering any comments about the quality of the investment advice offered in an April 23, 2014 article by StreetAuthority for the NASDAQ stock market website. The article is being featured here for informational purposes and because it focuses on nanotechnology (Note: A link has been removed),

A couple of months ago, the fund planners at Invesco PowerShares closed the book on one of the most unusual chapters in investing history, announcing a move to shut down the PowerShares Lux Nanotech Portfolio exchange-traded fund ( ETF ). A lack of interest was the main culprit in its demise.

… For many investors, the move signaled the end of the decade-long hype around nanotechnology stocks. Back in 2006, with nanotech mania in full bloom, Businessweek predicted that this emerging technology would represent a $2.6 trillion industry by 2014 .

That prediction overestimated the industry’s potential by at least $2.5 trillion.

StreetAuthority goes on to analyse some specific ‘nano’ stocks,

… A quick snapshot of where the remaining nanotech stocks trade in relation to their all-time highs paints a sobering picture. With the exception of FEI Co. (Nasdaq: FEIC ) , not one of these firms lived up to the hype.

[downloaded from http://www.nasdaq.com/article/is-the-nanotech-craze-over-not-for-these-2-stocks-cm346626]

[downloaded from http://www.nasdaq.com/article/is-the-nanotech-craze-over-not-for-these-2-stocks-cm346626]

Just when you think all is lost the author finds reason for optimism (Note: Links have been removed),

Yet just as most investors have written off the notion of nano-investing, the underlying technology is being seeded in a widening range of applications. Many industrial firms such as 3M (NYSE: MMM ) already derive solid recurring revenue streams from nanotechnology and are spending heavily on new products , which bodes well for the companies that make the tools to help further this technology’s development.

FEI, for example, is expected to reach the $1 billion revenue mark this year for the first time. FEI’s equipment helps other firms analyze and develop nanotechnology-based products and chemistries, mostly in the semiconductor industry. The company has delivered on the promise of nanotech, but shares appear fully valued, as top-line growth is around 10% and shares trade for more than 20 times next year’s earnings.

A more intriguingly valued stock is Flamel Technologies (Nasdaq: FLML ) , a biotech firm that has developed a range of drug delivery methods to deliver nano-sized particles into the bloodstream. Though this firm could never live up to the nanohype of a decade ago — and a decade of annual operating losses will wilt any investor’s confidence — shares are starting to rebound as key products start to reach the market.

It’s nice to be able to supplement the information one gets from government reports on commercializing nanotechnology with some ‘stock market’ analysis. As for whether or not this is good advice, caveat emptor (buyer beware). I can say that the author does not seem to have a solid grasp of the term ‘nanotechnology’, e.g. “… a new and much-hyped technology known as graphene holds the same promise , and in a few years we may see huge sums of money chase after graphene companies, just as we saw with nanotechs.” [emphasis mine] Generally speaking, graphene is considered to be part of the ‘nanotechnology enterprise’.